Loading
AP
Acerus Pharmaceuticals Corporation Stock: price and insider trades · Canada
Acerus Pharmaceuticals Corporation: what insiders have been doing
Acerus Pharmaceuticals Corporation is a listed company. Filings by its managers are published through SEDI. Acerus Pharmaceuticals Corporation has had no insider filing for more than a year; the last one goes back to 25 May 2022.
Over the whole record (from 2018), the tally stands at 46 purchases and no sales.
Source: insider filings from SEDI. Past trades are no guide to future returns.
Insider Decl.
72
Thresholds
n/a
Buy Volume
€1M
46 ops. · all time
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
Last declaration on 25 May 2022
Declarations72 total
100 shares@ CA$313.5080.3% of flowCommon SharesTSXSEDI:3950261
Canonical exit: 23 Aug 2022 (T+90)
Common SharesTSXSEDI:3943962
2,000 shares@ CA$3.797319.7% of flowCommon SharesTSXSEDI:3943963
Canonical exit: 10 Aug 2022 (T+90)
200 shares@ CA$4.5016.9% of flowCommon SharesTSXSEDI:3943609
Canonical exit: 9 Aug 2022 (T+90)
500 shares@ CA$4.520.2% of flowCommon SharesTSXSEDI:3943616
Canonical exit: 9 Aug 2022 (T+90)
100 shares@ CA$4.668.7% of flowCommon SharesTSXSEDI:3943611
Canonical exit: 9 Aug 2022 (T+90)
100 shares@ CA$4.538.5% of flowCommon SharesTSXSEDI:3943610
Canonical exit: 9 Aug 2022 (T+90)
100 shares@ CA$4.408.3% of flowCommon SharesTSXSEDI:3943608
Canonical exit: 9 Aug 2022 (T+90)
399,272 sharesCommon SharesTSXSEDI:3941381
922,457 sharesCommon SharesTSXSEDI:3941388
5,436,813 sharesCommon SharesTSXSEDI:3941387
106,124 sharesCommon SharesTSXSEDI:3941390
71,427 sharesCommon SharesTSXSEDI:3941384
485,013 sharesCommon SharesTSXSEDI:3941498
15,717,558 sharesCommon SharesTSXSEDI:3941365
3,961,218 sharesCommon SharesTSXSEDI:3908543
137,431 shares@ CA$0.025Common SharesTSXSEDI:3632952
3,125,327 shares@ CA$0.025Common SharesTSXSEDI:3632257
2,292,371 shares@ CA$0.025Common SharesTSXSEDI:3632256
24,585 shares@ CA$0.025Common SharesTSXSEDI:3632245
29,950 shares@ CA$0.025Common SharesTSXSEDI:3632255
509,368,574 shares@ CA$0.025Common SharesTSXSEDI:3632258
1,363,616 shares@ CA$0.025Common SharesTSXSEDI:3632232
400,000 shares@ CA$0.03Common SharesTSXSEDI:3626520
Canonical exit: 11 Feb 2021 (T+90)
Common SharesTSXSEDI:3568161
25 of 72 declarations
About Acerus Pharmaceuticals Corporation
Acerus Pharmaceuticals Corporation is a pharmaceutical company focused on the development and commercialization of health products. It is listed on the Toronto Stock Exchange under the symbol XTSE.
